Dr. Mitchell Felder, chief executive officer, founder and patent co- inventor of NanoLogix, commented, "In June 2006, we announced filing six patent applications for our hydrogen bioreactor and with these four additional patent applications, and others pending, we are solidifying a strong intellectual property position in the U.S. energy sector.

"Benchmarked against comparable-sized methane generating systems, NanoLogix can convert broader waste streams and byproducts, specifically industrial waste streams, to higher value hydrogen gas. Hydrogen offers a compelling, clean-burning alternative energy source, which the Company believes has tremendous commercial potential to power automobiles and provide electricity to manufacturing facilities, energy concerns and municipalities throughout the U.S."

A summary of the four patent applications follows:

1. System for sustained microbial production of hydrogen gas in a bioreactor -- Hydrogen is produced from microorganisms, by controlling the pH of the bioreactor between about 3.5 and 6.0 pH, and by heating the organic feed material prior to entry into the bioreactor. Further, the ORP of reactions occurring within the bioreactor are maintained at about -300 to -450 mV.

2. Method of hydrogen production in a bioreactor -- The hydrogen producing microorganisms metabolize an organic feed material substrat with a pH between 3.5 and 6.0 while in the bioreactor and is further heated prior to entry to de-activate or kill methanogens.

3. Production of hydrogen gas in a bioreactor with coated substrates -- The bioreactor provides an environment conducive to the breakdown of aqueous material and the production of hydrogen from nonparaffinophilic microorganisms, which are baited and grown on a gelatinous matrix. The bioreactor includes substrates coated with a gelatinous matrix.

4. Method of producing hydrogen gas and isolation of hydrogen producing microorganisms using replenishing coated substrates -- This method produces hydrogen by baiting and growing nonparaffinophilic microorganisms on a gelatinous matrix that restricts the production of methane. The gelatinous matrix coating is replenished by additional coating material into interior channels of the substrates.

About NanoLogix, Inc.

NanoLogix is an industry innovator in the research, development and commercialization of nano-biotechnologies, applications and processes. The Company owns or has the rights to 32 patented technologies. The Company is currently focused on the production of hydrogen from agricultural feedstock, industrial wastewater and municipal waste streams to create new sources of energy. NanoLogix is successfully operating a hydrogen bioreactor at Welch's Food and has recently signed an agreement with the City of Erie Wastewater Treatment Plant for a prototype bioreactor installation. Additionally, NanoLogix develops and markets diagnostic test kits for use in early detection of infectious human diseases such as cancer, cystic fibrosis and AIDS, and owns a patent for the non-toxic induction of apoptosis ("cell suicide") for the treatment of cancer. For more information on the Company, visit http://www.nanologix.net